Pneumococcal polysaccharide vaccine
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID), Henry M. Jackson Foundation for the Advancement of Military Medicine, Sanofi Pasteur, a Sanofi Company, Ewha Womans University, Helsinki University Central Hospital
Conditions
AgedDengue DiseasesDengue FeverDengue Hemorrhagic FeverDengue VirusHIV InfectionsMultiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Phase 2
Phase 3
Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting
CompletedNCT00622843
Start: 2002-12-31End: 2013-07-31Updated: 2025-06-08
Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy
CompletedNCT05028634
Start: 2021-11-11End: 2023-11-15Updated: 2025-02-11
Phase 4
Unknown Phase
Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs
CompletedNCT00257127
Start: 2006-02-28End: 2006-08-31Updated: 2021-11-01
Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients
CompletedNCT02547493
Start: 2016-03-03End: 2021-01-18Updated: 2022-01-03